Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1566 of 5804
-
Contrast-Enhanced mammography: sharper images to catch hidden breast cancers?
Diagnosis OngoingThis clinical trial examines a new imaging technology, contrast-enhanced mammography, in predicting breast cancer. Contrast-enhanced mammography is similar to standard mammography, but it includes an intravenous (by vein) injection of iodine-based contrast, which makes tissue and…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Could a daily pill help save sight in diabetic retinopathy?
Disease control CompletedThe objective of this study is to evaluate the safety and efficacy of APX3330 to treat diabetic retinopathy (DR) and diabetic macular edema (DME).
Phase: PHASE2 • Sponsor: Ocuphire Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Psoriasis breakthrough? single shot may keep skin clear for over a year
Knowledge-focused CompletedAlthough the newly developed biologics (drugs derived from living cells cultured in a laboratory) are highly effective in controlling psoriasis, all the biologics should be continuously injected to suppress recurrence of the disease. In this regard, the observation in the phase I…
Phase: PHASE4 • Sponsor: Jaehwan Kim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New eczema cream shows promise for kids ages 2-5
Symptom relief CompletedThis was a Phase 3, 4-week, double-blind study to assess the safety and efficacy of ARQ-151 cream compared to vehicle cream applied once daily (qd) for 4 weeks in children 2 to 5 years of age with atopic dermatitis (AD).
Phase: PHASE3 • Sponsor: Arcutis Biotherapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Cancer combo trial halted early – what went wrong?
Disease control TerminatedTreatment will consist of a PARP inhibitor (niraparib) monotherapy priming period (cycle 0; 21 days); an anti-PD-1 antibody (Dostarlimab ; TSR-042) will then be added from C1D1 every 21 days in combination for the first 4 cycles, and then every 42 days. Disease will be assessed e…
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
IVF breakthrough? new test spots healthy embryos in minutes!
Knowledge-focused CompletedThis study aims to validate the embryo culture medium analysis by nuclear magnetic resonance spectroscopy, as a faster and less-costly alternative to preimplantation genetic test for aneuploidy which could significantly enhance embryo selection and the success rate of assisted re…
Sponsor: Instituto Valenciano de Infertilidade de Lisboa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New scan spots prostate cancers standard MRI misses
Diagnosis TerminatedThis prospective trial aims to determine if enhanced prostate imaging using two novel imaging technologies (high resolution DWI and 18F-PSMA PET-MRI) will detect prostate cancers not seen on standard multiparametric prostate MRI in patients considered candidates for focal HIFU.
Phase: PHASE2 • Sponsor: Alessandro D'Agnolo • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
New psoriasis drug shows promise for teens in early trial
Disease control CompletedThe purpose of the study is to assess th pharmacokinetics (PK) of bimekizumab administered subcutaneously (sc) in adolescents with moderate to severe plaque psoriasis (PSO).
Phase: PHASE2 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
AML drug venetoclax under Real-World watch in south korea
Disease control CompletedAcute Myeloid Leukemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible for fighting infections). This study will assess how safe and effective oral venetoclax is in participants with AML . Adverse events and change in disease activity will …
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could zapping the brain help beat opioid addiction?
Disease control Recruiting nowThe purpose of this study is to assess the effects of transcranial Direct Current Stimulation (tDCS) applied in conjunction with Transcranial Ultrasound (TUS) for the treatment of addiction in opiate use disorder with chronic pain. The investigators hypothesize that there will be…
Phase: NA • Sponsor: Case Western Reserve University • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Anti-Aging pill? MitoQ trial targets blood vessel decline in seniors
Disease control OngoingThe majority of cardiovascular diseases (CVD) occur in men and women ≥60 years of age. Vascular dysfunction, including endothelial dysfunction, as assessed by reduced endothelium-dependent dilation (EDD), and stiffening of the large elastic arteries (i.e., aortic and carotid arte…
Phase: PHASE2 • Sponsor: University of Colorado, Boulder • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Glow-in-the-Dark dye helps surgeons spot hidden cancer
Diagnosis Recruiting nowThe purpose of this study is to determine if panitumumab-IRDye800 is effective in identifying cancer, compared to surrounding normal tissue, and the further characterize the safety profile of this drug.
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Could a simple hormone boost improve IVF success?
Disease control CompletedThe study aims to evaluate the effect of an increased dose of vaginal progesterone supplementation on the incidence of ongoing pregnancy for patients with a suboptimal serum progesterone level (defined as \< 10 mcg/l) on the day of blastocyst transfer.
Phase: PHASE3 • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for kids with rare blood disorder: trametinib trial launches
Disease control Recruiting nowProspective, interventional, open, randomized, single-center, non-commercial clinical trial to optimize treatment and dosage of trametinib in juvenile patients with histiocytosis resistant to conventional therapy and without the BRAF gene mutation or after the failure of vemurafe…
Phase: PHASE2 • Sponsor: Anna Raciborska • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
AI-Powered MRI could revolutionize prostate cancer detection
Diagnosis Recruiting nowThis study evaluates how new magnetic resonance imaging (MRI) and artificial intelligence techniques improve the image quality and quantitative information for future prostate MRI exams in patients with suspicious of confirmed prostate cancer. The MRI and artificial intelligence …
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New imaging test could spot rare childhood disease sooner
Diagnosis Recruiting nowProspective, low intervention, open, single-center, non-commercial clinical trial to improve diagnostics in patients with histiocytosis by assessing the molecular profile of the tumor tissues, monitoring its presence in free-circulating DNA, and determining the efficacy of fluoro…
Phase: PHASE3 • Sponsor: Anna Raciborska • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Could a common heart pill boost cancer therapy? new trial explores propranolol for esophageal cancer
Disease control Recruiting nowThis phase II trial studies the side effects and best dose of propranolol when administered concurrently with SOC neoadjuvant CRT in patients with esophageal carcinoma, with a safety lead-in and dose expansion cohort. Patients who are already on β-blockers will receive standard o…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Blow into this tube: a simple breath test might spot liver disease early
Diagnosis CompletedThis study aims to determine whether a breath test could be used for early detection of hepatic fibrosis, cirrhosis or hepatocellular carcinoma. Patients who are attending for a planned liver outpatient services or investigations will be approached to provide a breath sample. M…
Sponsor: Imperial College London • Aim: Diagnosis
Last updated Jun 27, 2026 12:02 UTC
-
Could an arthritis drug tame OCD? new study investigates
Symptom relief TerminatedThe goal of this study is to examine whether measurements of inflammation from brain scanning and blood tests can predict how much benefit patients with obsessive-compulsive disorder (OCD) will have from treatment with an anti-inflammatory medication, celecoxib, when adding to on…
Phase: PHASE2 • Sponsor: New York State Psychiatric Institute • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New care pathway aims to save lives of ICU patients with breathing failure
Disease control OngoingTreatment of patients with Hypoxemic respiratory failure (HRF) and Acute Respiratory Distress Syndrome (ARDS) is complex. Therapies that have been shown to save the lives of patients with HRF and ARDS are available but they are not always provided. To reduce practice variation an…
Phase: NA • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC